Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: New Appointments at Lunaphore, Meridian Bioscience, Oxford Nanopore, More

Lunaphore: Alice Feng

Swiss spatial biology company Lunaphore has hired Alice Feng as CFO, effective Jan. 31. Feng most recently served as CFO of Scripps Research. She joined Scripps as senior director of corporate development and finance in 2017. Prior to that Feng worked with Scripps Health and Aetna as senior director of corporate development, and earlier in her career she spent more than 11 years in investment banking including with Merrill Lynch and Morgan Joseph. Feng holds a B.S. in business economics and microbiology and molecular genetics from the University of California, Los Angeles.

Meridian Bioscience: John McIlwraith

Meridian Bioscience announced that John McIlwraith has been elected chairman of the firm's board of directors. McIlwraith is managing director at technology venture capital firm Allos Ventures and was previously managing director of Blue Chip Venture Company. He was also previously senior VP of strategic planning and general counsel of Quantum Health Resources and a partner at Jones Day law firm. McIlwraith has served on the boards of more than 20 healthcare and information technology companies, including as chairman and lead director of pharmacogenetic testing company Assurex Health. He was appointed to Meridian's board in 2015.

Oxford Nanopore Technologies: Wendy Becker

Oxford Nanopore Technologies has appointed Wendy Becker as senior independent director. Becker joined Oxford Nanopore in June 2021 as an independent non-executive director. Prior to joining the company, she served as chair for Logitech International, non-executive director of Sony, and member of the council of the University of Oxford.

For additional recent items on executive appointments and promotions in omics and molecular diagnostics, please see the People in the News page on our website.

The Scan

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.

New Oral Nanomedicine Strategy Targets Gut-Brain Axis to Treat IBD

A new paper in Science Advances describes a platform to design polyphenol-armored oral medicines that are effective at treating inflammatory bowel disease.

Phylogenetic Data Enables New Floristic Map

Researchers in Nature Communications use angiosperm phylogenetic data to refine the floristic regions of the world.

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.